AKT1 and urinary bladder cancer: Wu X et al (2004) showed that a specific inhibitor of PI3 kinase enzyme activity, Ly294002, potently suppressed the invasive properties of three highly invasive bladder tumour cell lines and 55% of primary tumours from patients with bladder cancer had markedly high levels of phosphorylated Akt [26].